These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells. Sasaoka T, Kikuchi K, Wada T, Sato A, Hori H, Murakami S, Fukui K, Ishihara H, Aota R, Kimura I, Kobayashi M. Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696 [Abstract] [Full Text] [Related]
29. Different designs of kinase-phosphatase interactions and phosphatase sequestration shapes the robustness and signal flow in the MAPK cascade. Sarma U, Ghosh I. BMC Syst Biol; 2012 Jul 02; 6():82. PubMed ID: 22748295 [Abstract] [Full Text] [Related]
30. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity. Bardwell AJ, Abdollahi M, Bardwell L. Biochem J; 2003 Mar 15; 370(Pt 3):1077-85. PubMed ID: 12529172 [Abstract] [Full Text] [Related]
34. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Ugi S, Imamura T, Maegawa H, Egawa K, Yoshizaki T, Shi K, Obata T, Ebina Y, Kashiwagi A, Olefsky JM. Mol Cell Biol; 2004 Oct 15; 24(19):8778-89. PubMed ID: 15367694 [Abstract] [Full Text] [Related]
35. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands. Arsenault RJ, Kogut MH, He H. Cell Signal; 2013 Nov 15; 25(11):2246-54. PubMed ID: 23876795 [Abstract] [Full Text] [Related]
37. Therapeutic challenges of kinase and phosphatase inhibition and use in anti-diabetic strategy. Bridges AJ. Biochem Soc Trans; 2005 Apr 15; 33(Pt 2):343-5. PubMed ID: 15787602 [Abstract] [Full Text] [Related]